The trademark ACTIFLEX was filed by LABOPHAR, naamloze vennootschap, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on September 13, 2022, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on December 13, 2022 by Orifarm Generics A/S on Likelihood of confusion. the opponent was represented by Bugge Valentin Advokatpartnerselskab and its proceedings were handled in English The second opposition filed on December 13, 2022 by JNTL Consumer Health I (Switzerland) GmbH on Likelihood of confusion. the opponent was represented by D YOUNG & CO LLP and its proceedings were handled in English
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).
A total of undefined cancellation proceedings were initiated against the trademark registration in 2023.The first Cancellation was filed by Hermes Arzneimittel GmbH (represented by Isarpatent - Patent- und Rechtsanwälte Barth · Charles · Hassa · Peckmann & Partner mbB) on December 9, 2024 and Appeal pending.
Change of name and professional address of the trademark registration was recorded on May 8, 2023. Change of name and address of the trademark registration was recorded on May 18, 2023. Appointment and Replacement of representative of the trademark registration was recorded on July 2, 2023. Application for revocation or for a declaration of invalidity of the trademark registration was recorded on July 13, 2023. Appointment and Replacement of representative of the trademark registration was recorded on July 30, 2023. A transfer of the trademark registration was recorded on April 17, 2025.
The Cancellation with reference B 000061085 was Cancellation rejected according to Article 7(1)(b) EUTMR with decision issued on October 20, 2024 by the EUIPO. The Appeal with reference B R2381/2024-2 was Trade mark remains valid according to Article 59(1)(a) EUTMR with decision issued on July 7, 2025 by the EUIPO.